U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Fallntolol is a beta-adrenergic receptor antagonist. Falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy.

Originator

Curator's Comment: reference retrieved from https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6

Approval Year

PubMed

PubMed

TitleDatePubMed
Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
1989-12
Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution.
1987-01
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
1987
New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent beta-adrenergic blocking properties.
1985-07
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
1985-04
Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
1984-10
Substance Class Mixture
Created
by admin
on Mon Mar 31 23:46:18 GMT 2025
Edited
by admin
on Mon Mar 31 23:46:18 GMT 2025
Record UNII
733BXR9780
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CYCLOPROPYL METHYL KETONE, (±)-(EZ)-O-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL)OXIME
Preferred Name English
FALINTOLOL
INN  
INN  
Official Name English
ETHANONE, 1-CYCLOPROPYL-, O-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPYL)OXIME
Systematic Name English
FALINTOLOL, (E/Z)-(±)-
Common Name English
falintolol [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29576
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
Code System Code Type Description
CAS
88134-91-2
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
ALTERNATIVE
NCI_THESAURUS
C73016
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
CAS
90581-63-8
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
MESH
C045888
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL111103
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID301024755
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
FDA UNII
733BXR9780
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
SMS_ID
100000081552
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
INN
5598
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
EVMPD
SUB07499MIG
Created by admin on Mon Mar 31 23:46:18 GMT 2025 , Edited by admin on Mon Mar 31 23:46:18 GMT 2025
PRIMARY
All of the following components must be present:
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Definition References